Viewing Study NCT00106834


Ignite Creation Date: 2025-12-25 @ 2:28 AM
Ignite Modification Date: 2026-06-29 @ 9:22 PM
Study NCT ID: NCT00106834
Status: COMPLETED
Last Update Posted: 2011-05-19
First Post: 2005-03-31
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of the Safety and Efficacy of Infliximab in Patients With Psoriasis
Sponsor: Centocor, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Psoriasis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Psoriasis View
None Infliximab View
None Remicade View